Back
Berkshire Hathaway, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
49
BRK.A
Berkshire Hathaway, Inc.
Last Price:
$755,500.00
Seasonality Move:
7.44%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$771.83
Seasonality Move:
12.13%
Sell
49
Berkshire Hathaway, Inc. (BRK.A)
is a Sell
Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?
-
The current Berkshire Hathaway, Inc. [BRK.A] share price is $752,000.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $780.50. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRK.A Stock Price Chart
What is Berkshire Hathaway, Inc.'s stock price today?
-
The Berkshire Hathaway, Inc. share price today is $752,000.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $780.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 38.06 | Buy |
| Relative Strength Index (14 RSI): | 51.25 | Buy |
| Chaikin Money Flow: | 389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (753331.03 - 753347.03) | Sell |
| Bollinger Bands (100): | (742025.24 - 742055.24) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 216.48 | Buy |
| Relative Strength Index (14 RSI): | 65.27 | Buy |
| Chaikin Money Flow: | 70647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (725.9 - 779.36) | Buy |
| Bollinger Bands (100): | (557.81 - 715.59) | Buy |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 751028.83 | Buy |
| 20-day SMA: | 750709.51 | Buy |
| 50-day SMA: | 746557.3 | Buy |
| 200-day SMA: | 747457.15 | Buy |
| 8-day EMA: | 750333.48 | Buy |
| 20-day EMA: | 750713.99 | Buy |
| 50-day EMA: | 748249.25 | Buy |
| 200-day EMA: | 735623.15 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 772.52 | Buy |
| 20-day SMA: | 747.31 | Buy |
| 50-day SMA: | 699.49 | Buy |
| 200-day SMA: | 602.77 | Buy |
| 8-day EMA: | 674.04 | Buy |
| 20-day EMA: | 427.09 | Buy |
| 50-day EMA: | 211.88 | Buy |
| 200-day EMA: | 59.42 | Buy |
Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates
-
Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,675.77 per share, and an increase next year of $3,470.08 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $1.14 per share.
Berkshire Hathaway, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||